Valgerður Rúnarsdóttir, Medical Director at SÁÁ
40 ára afmælisráðstefna SÁÁ: Opioid addiction in Iceland SÁÁ Valgerður Rúnarsdóttir, MD, Medical Director at SÁÁ Abstract In Iceland, the opioid addiction problem is because of prescription opioid almost solely. Heroin is not generally found on the black market but prescription tablets are. Prescription drugs are part of the addiction problem in general, like in other …Read more »
Sigurður Ólafsson, Director of Hepatology
40 ára afmælisráðstefna SÁÁ: Treatment as prevention for hepatitis C (TraP HepC): A nationwide elimination program in Iceland Sigurður Ólafsson, MD, FACP, Director of Hepatology, Division of Gastroenterology, Department of Medicine Landspitali University Hospital Abstract Hepatitis C virus (HCV) infection is one of the leading causes of cirrhosis and hepatocellular carcinoma worldwide. Injection drug use is …Read more »
Þórólfur Guðnason, Chief Epidemiologist
Seminar: Viral infections and addiction, HIV and Hepatitis C Chair – Þórólfur Guðnason MD, PhD, Chief Epidemiologist, Centre for Health Security and Communicable Disease Control, Directorate of Health
George Woody, Perelman School of Medicine
40 ára afmælisráðstefna SÁÁ: International research on addiction treatment George Woody MD, Professor, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania Abstract The HIV epidemic generated a high level of interest in addiction research, particularly treatment research, due to it association with injecting drug use, and drug use and unprotected sex. The result …Read more »
Frank Vocci, Pres., Friends Research Institude
40 ára afmælisráðstefna SÁÁ: New approaches to developing medications for helping smokers quit Frank J. Vocci, PhD, President, Friends Research Institute Abstract Tobacco smoking is the leading cause of preventable death in many developed countries. Nicotine replacement therapy (NRT) medications can double an individual’s chances of quitting but relapse is frequent. The majority of NRT …Read more »
Nora D. Volkow, Director of NIDA
40 ára afmælisráðstefna SÁÁ: Cannabis and society – can science guide public policies? Nora Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) Nora D. Volkow, M.D., became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. Dr. …Read more »
Kári Stefánsson, CEO Decode Genetics
Kári Stefánsson, M.D., Dr. Med. has served as President, Chief Executive Officer and a Director since he founded deCODE genetics in August 1996. Dr. Stefánsson was appointed the Chairman of the Board of Directors of deCODE genetics in December 1999. From 1993 until April 1997, Dr. Stefánsson was a professor of Neurology, Neuropathology and Neuroscience …Read more »
Arndís Sue Ching Löve, PhD student MS Pharm
40 ára afmælisráðstefna SÁÁ: Estimation of community drug abuse in the Reykjavík metropolitan area by wastewater analysis Arndís Sue Ching Löve, PhD student MS Pharm Abstract Introduction: Drug abuse has been a matter of concern worldwide due to the risks these substances pose to human health, and their connection to crime. Sewage epidemiology is a methodology used …Read more »
Nora D. Volkow, Director of the NIDA
40 ára afmælisráðstefna SÁÁ Nora D. Volkow, M.D., became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. Dr. Volkow’s work has been instrumental in demonstrating that drug addiction is a disease of the human brain. As a research psychiatrist and scientist, Dr. Volkow pioneered the …Read more »
